Epstein-barr virus

Mucocutaneous Manifestations of Viral Diseases

Volumn , Issue , 2002, Pages 145-172

  Walling, Dennis M ^a   Hudnall, S David ^a   Yen Moore, Angela ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8744264112     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (156)

1. D Liebowitz, E Kieff. Epstein-Barr virus. In: B Roizman, RJ Whitley, C Lopez, eds. The Human Herpesviruses. New York: Raven Press, 1993, pp 107-172.
2. MA Epstein, BG Achong, YM Barr. Virus particles in cultured lymphocytes Burkitt’s lymphoma. Lancet 1: 702-703, 1964.
3. G Henle, W Henle, V Diehl. Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59:94-101, 1968.
4. MS Pereira, JM Blake, AD Macrae. EB virus antibody at different ages. BMJ 4:526-527, 1969.
5. G Henle, W Henle, CA Horowitz. Epstein-Barr virus specific diagnosis tests in infectious mononucleosis. Hum Pathol 5:551-565, 1974.
6. CW Heath Jr., AL Brodsky, AI Potolsky. Infectious mononucleosis in a general population. Am J Epidemiol 95: 46-52, 1972.
7. G Miller, JC Niederman, LL Andrews. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med 288:229-232, 1973.
8. AK Junker, EE Thomas, AGI Radcliffe, RB Forsyth, AG Davidson, L Rymo. Epstein-Barr virus shedding in breast milk. Am J Med Sci 302:220-223, 1991.
9. V Israele, P Shirley, JW Sixbey. Excretion of the Epstein-Barr virus from the genital tract of men. J Infect Dis 163: 1341-1343, 1991.
10. JW Sixbey, SM Lemon, JS Pagano. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 2: 1122-1124, 1986.
11. M-C Meyohas, V Marechal, N Desire, J Bouillie, J Frottier, JC Nicolas. Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J Virol 70: 6816-6819, 1996.
12. JH Joncas, C Alfieri, M Leyritz-Wills, P Brochu, G Jasmin, I Boldogh, ES Huang. Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med 304:1399-1403, 1981.
13. GN Goldberg, VA Fulginiti, CG Ray, P Ferry, JF Jones, H Cross, L Minnich. In utero Epstein-Barr virus (infectious mononucleosis) infection. JAMA 246:1579-1581, 1981.
14. H Cen, MC Breinig, RW Atchison, M Ho, JLC McKnight. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 65:976-980, 1991.
15. S Swaminathan, R Hesselton, J Sullivan, E Kieff. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol 67:7406-7413, 1993.
16. S Henderson, D Huen, M Rowe, C Dawson, G Johnson, A Rickinson. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90: 8479-8483, 1993.
17. R Pathmanathan, U Prasad, R Sadler, K Flynn, N Raab-Traub. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698, 1995.
18. NR Cooper, MD Moore, GR Nemerow. Immunobiology of CR2, the B lymphocyte receptor for the Epstein-Barr virus and C3d complement fragment. Annu Rev Immunol 6:85-113, 1988.
19. J Yates, N Warren, D Reisman, B Sugden. A cis acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81:3806-3810, 1984.
20. J Levitskaya, M Coram, V Levitsky, S Imreh, PM Steiger-wald-Mullen, G Klein, MG Kurilla, MG Masucci. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688, 1995.
21. CL Miller, AL Burkhardt, JH Lee, B Stealey, R Long-necker, JB Bolen, E Kieff. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166, 1995.
22. JW Gratama, MAP Oosterveer, FE Zwaan, J Lepoutre, G Klein, I Ernberg. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A 85: 8693-8696, 1988.
23. MG Masucci, I Ernberg. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol 2: 125-130, 1994.
24. JF Jones, S Shurin, C Abramowsky, RR Tubbs, CG Sciotto, R Wahl, J Sands, D Gottman, BZ Katz, J Sklar. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733-741, 1988.
25. H Kikuta. Epstein-Barr virus-associated hemophagocytic syndrome. Leuk Lymphoma 16:425-429, 1995.
26. J Sixbey, Q Yao. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578-1580, 1992.
27. LS Wilkinson, LD Petz, G Garraty. Reappraisal of the role of anti-i in haemolytic anemia in infectious mononucleosis. Br J Haematol 25:715-722, 1973.
28. LM Kernoff. Demonstration of increased platelet bound IgG in infectious mononucleosis complicated by severe thrombocytopenia. Scand J Infect Dis 12:67-69, 1980.
29. JW Sixbey, JG Nedrud, N Raab-Traub, RA Hanes, JS Pagano. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225-1230, 1984.
30. RT Schooley. Epstein-Barr virus (infectious mononucleosis). In: GL Mandell, JE Bennett, R Dolin, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, Inc, 1995, pp 1364-1377.
31. CV Sumaya. Epstein-Barr virus infection: the expanded spectrum. Adv Pediatr Infect Dis 1:75-97, 1986.
32. JT McCarthy, RJ Hoagland. Cutaneous manifestations of infectious mononucleosis. JAMA 187:153, 1964.
33. U Baldari, C Cancellieri, B Celli, R Zanelli, AA Raccagni. Skin disorders and Epstein-Barr virus primary infection: results of a 31 month survey. J Eur Acad Dermatol Vener-eol 4:239-247, 1995.
34. AW Contratto. Infectious mononucleosis: a study of one hundred and ninety-six cases. Arch Intern Med 73: 449-459, 1944.
35. JA Africk, KM Halprin. Infectious mononucleosis presenting as urticaria. JAMA 209:1524-1525, 1969.
36. BM Andersen Lund, T Bergan. Temporary skin reactions to penicillins during the acute stage of infectious mononucleosis. Scand J Infect Dis 7:21-28, 1975.
37. H McKenzie, D Parratt, RG White. IgM and IgG antibody levels of ampicillin in patients with infectious mononucleosis. Clin Exp Immunol 26:214-221, 1976.
38. R Mulroy. Amoxicillin rash in infectious mononucleosis. BMJ 1:554, 1973.
39. F Drago, F Crovato, A Rebora. Gianotti-Crosti syndrome as a presenting sign of EBV-induced acute infectious mononucleosis. Clin Exp Dermatol 22:300-304, 1997.
40. L Lowe, AA Hebert, M Duvic. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. J Am Acad Dermatol 20:336-338, 1989.
41. A Taieb, P Plantin, P Du Pasquier, G Guillet, J Maleville. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol 115:49-59, 1986.
42. F Drago, M Romagnoli, A Loi, A Rebora. Epstein-Barr virus-related persistent erythema multiforme in chronic fatigue syndrome. Arch Dermatol 128:217-222, 1992.
43. DM Williamson. Erythema multiforme in infectious mononucleosis. Br J Dermatol 91:345-346, 1974.
44. HJ Bodansky. Erythema nodosum and infectious mononucleosis. BMJ 2:1263, 1979.
45. SC Cowdrey, JS Reynolds. Acute urticaria in infectious mononucleosis. Ann Allergy 27:182-187, 1969.
46. CJ Tyson, D Czarny. Cold induced urticaria in infectious mononucleosis. Med J Aust 1:33-35, 1981.
47. SE Straus, JI Cohen, G Tosato, J Meier. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118:45-58, 1993.
48. H Hammar. Erythema annulare centrifugum coincident with Epstein-Barr virus in an infant. Acad Pediatr Scand 63:788-792, 1974.
49. JM Boss, JD Boxley, R Summerly, RN Sutton. The detection of Epstein-Barr virus antibody in exanthematic dermatoses with special reference to pityriasis lichenoides. A preliminary survey. Clin Exp Dermatol 3:51-56, 1978.
50. JW Petrozzi. Infectious mononucleosis manifesting as palmar dermatitis. Arch Dermatol 104:207-209, 1971.
51. SA Spencer, NA Fenske, CG Espinoza, JR Hamill, LE Cohen, LR Espinoza. Granuloma annulare-like eruption due to chronic Epstein-Barr virus infection. Arch Dermatol 124:250-255, 1988.
52. F Drago, A Parodi, A Rebora. Gloves-and-socks syndrome in a patient with Epstein-Barr virus. Dermatology 194:374, 1997.
53. J Portnoy, GA Ahronheim, F Ghibu, B Clecner, JH Joncas. Recovery of Epstein-Barr virus from genital ulcers. N Engl J Med 311:966-968, 1984.
54. U Baldari, AA Raccagni, B Celli, MG Righini. Chronic bullous disease of childhood following Epstein-Barr virus seroconversion: a case report. Clin Exp Dermatol 21: 123-126, 1996.
55. F Drago, E Ranieri, A Pastorino, S Casazza, F Crovato, A Rebora. Epstein-Barr virus-related cutaneous amyloidosis. Successful treatment with acyclovir and interferonalpha. Br J Dermatol 134:170-174, 1996.
56. J-P Fermand, J Gozlan, A Bendelac, MC Delauche-Caval-lier, JC Brouet, F Morinet. Detection of Epstein-Barr virus in epidermal skin lesions of an immunocompromised patient. Ann Intern Med 112:511-515, 1990.
57. RL Carter. Platelet levels in infectious mononucleosis. Blood 25:817-821, 1964.
58. ML Pipp, ND Means, JW Sixbey, KL Morris, CL Gue, LM Baddour. Acute Epstein-Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 25: 1237-1239, 1997.
59. RS Tomsick. The phenytoin syndrome. Cutis 32:535-541, 1983.
60. AS Evans, JC Niederman, LC Cenabre, B West, VA Richards. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J Infect Dis 132:546-554, 1975.
61. CV Sumaya, Y Ench. Epstein-Barr virus mononucleosis in children. II. Heterophile antibodies and viral specific responses. Pediatrics 75:1011-1019, 1985.
62. C Van der Horst, J Joncas, G Ahronheim, N Gustafson, G Stein, M Gurwith, G Fleisher, J Sullivan, J Sixbey, S Roland, et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 164:788-792, 1991.
63. QY Yao, P Ogan, M Rowe, M Wood, AB Rickinson. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 43:67-71, 1989.
64. E Tynell, E Aurelius, A Brandell, I Julander, M Wood, QY Yao, A Rickinson, B Akerlund, J Andersson. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 174:324-331, 1996.
65. AM Levine. Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20, 1992.
66. E Brusamolino, G Pagnucco, C Bernasconi. Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanisms. Haematologica 74: 605-622, 1989.
67. JI Cohen. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70: 137-160, 1991.
68. N Mueller, A Evans, NL Harris, GW Comstock, E Jellum, K Magnus, N Orentreich, BF Polk, J Vogelman. Hodgkin’s disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 320:689-695, 1989.
69. IJ Su. Epstein-Barr and T cell lymphomas. Epstein-Barr Virus Report 3:1-6, 1996.
70. SA Ridler, MC Breinig, JC McKnight. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984, 1994.
71. PJ Farrell. Epstein-Barr virus immortalizing genes. Trends Microbiol 3:105-109, 1995.
72. SA Henderson, D Huen, M Rowe. Epstein-Barr virus transforming proteins. Semin Virol 5:391-399, 1994.
73. JM McGregor, CC-W Yu, QL Lu, FE Cotter, DA Levison, DM MacDonald. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 29:549-554, 1993.
74. S Piluso, S Di Lollo, G Baroni, F Leoncini, D Gaglioti, A Saccardi, G Ficarra. Unusual clinical aspects of oral non-Hodgkin lymphomas in patients with HIV infection. Eur J Cancer B Oral Oncol 30B:61-64, 1994.
75. GD Palmer, PR Morgan, SJ Challacombe. T-cell lymphoma associated with periodontal disease and HIV infection: a case report. J Clin Periodontol 20:378-380, 1993.
76. HJ Delecluse, I Anagnostopoulos, F Dallenbach, M Hummel, T Marafioti, U Schneider, D Huhn, A Schmidt-Westhausen, PA Reichart, U Gross, H Stein. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89: 1413-1420, 1997.
77. JA Thomas, F Cotter, AM Hanby, LQ Long, PR Morgan, B Bramble, BM Bailey. Epstein-Barr virus-related oral T-cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood 81:3350-3356, 1993.
78. I Anagnostopoulos, M Hummel, P Kaudewitz, P Korbjuhn, L Leoncini, H Stein. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoprolifer-ations. Br J Dermatol 134:276-281, 1996.
79. CA Angel, DN Slater, JA Royds, SNP Nelson, SS Bleehen. Absence of Epstein-Barr viral encoded RNA in primary cutaneous T-cell lymphoma. J Pathol 178:173-175,1996.
80. N Misago, K Ohshims, S Aiura, M Kikuchi, H Kohda. Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: association with Epstein-Barr virus. Br J Dermatol 135:638-643, 1996.
81. CK Park, YH Ko. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin: an in situ hybridization study. Br J Dermatol 134:488-493, 1996.
82. IJ Su, TF Tsai, AL Cheng, CC Chen. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. J Am Acad Dermatol 29:685-692, 1993.
83. TF Tsai, IJ Su, YC Lu, HP Yeh, HC Hsieh, HF Tien, JS Chen, WC Uen. Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol 26:31-38, 1992.
84. R Pathmanathan, U Prasad, G Chandrika, R Sadler, K Flynn, N Raab-Traub. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx: variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146:1355-1367, 1995.
85. AF Jarrett, AA Armstrong, E Alexander. Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol 7(suppl 4): 5-10, 1996.
86. LM Weiss, LA Movahed, RA Warnke, J Sklar. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502-506, 1989.
87. K Iwatsuki, M Ohtsuka, H Harada, G Han, F Kaneko. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 133:1081-1086, 1997.
88. WA Andiman. EBV-associated syndromes: a critical reexamination. Pediatr Infect Dis 3:198-203, 1984.
89. W Henle, G Henle. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 41:4222-4225, 1981.
90. M Okano, GM Thiele, JR Davis, HL Grierson, DT Purtilo. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1:300-312, 1988.
91. JHC Ho, MH Ng, HC Kwan, JCW Chau. Epstein-Barr virus specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer 34:655-659, 1976.
92. EM MacMahon, RF Ambinder. EBER in situ hybridization: sensitive detection of latent Epstein-Barr virus in individual cells. Rev Med Virol 4:251-260, 1994.
93. JS Greenspan, D Greenspan, E Lennette, DI Abrams, MA Conant, V Petersen, UK Freese. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564-1571, 1985.
94. N Raab-Traub, K Flynn. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889, 1986.
95. L Pedneault, BZ Katz. Comparison of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens. J Med Virol 39:33-43, 1993.
96. DW Hanto. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 46:381-394, 1995.
97. L Young, C Alfieri, K Hennessy, H Evans, C O’Hara, KC Anderson, J Ritz, RS Shapiro, A Rickinson, E Kieff, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoprolifer-ative disease. N Engl J Med 321:1080-1085, 1989.
98. BZ Katz, N Raab-Traub, G Miller. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589-598, 1989.
99. JL Sullivan, P Medveczky, SJ Forman, SM Baker, JE Monroe, C Mulder. Epstein-Barr virus-induced lympho-proliferation: implications for antiviral chemotherapy. N Engl J Med 311:1163-1167, 1984.
100. CM Rooney, CA Smith, CYC Ng, S Loftin, C Li, RA Krance, MK Brenner, HE Heslop. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9-13, 1995.
101. A Yen, P Fearneyhough, SS Ramier, SD Hudnall. EBV-associated Kikuchi’s histiocytic necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol 36: 342-346, 1997.
102. M Kikuchi. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes: a clinico-pathological study. Nippon Ketsueki Gakkai Zassho 35: 379-380, 1972.
103. Y Fujimoto, Y Kojima, K Yamaguchi. Cervical subacute necrotizing lymphadenitis. Naika 30:920-927, 1972.
104. Y Sumiyoshi, M Kikuchi, T Minematu, K Ohshima, M Takeshita, Y Minamishima. Analysis of herpesvirus genomes in Kikuchi’s disease. Virchows Arch 424:437-440, 1994.
105. AC Feller, K Lennert, H Stein, HD Bruhn, HH Wuthe. Immunohistology and etiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases. Histopa-thology 7:825-839, 1983.
106. S Pasquinucci, M Conisi, F Cavinato, F Bolussi. Kikuchi’s disease in a patient infected with AIDS (letter). AIDS 5: 235, 1991.
107. SA Pileri, E Sabattini, P Costigliola, S Poggi, E Ricchi, F Tumietto, F Chiodo. Kikuchi’s lymphadenitis and HIV infection. AIDS 5:459-461, 1991.
108. O Meyer, P Ribard, N Belmatoug, MF Kahn, M Grossin, JC Fournet, C Darne, F Morinet. Trois cas de lymphadenite de Kikuchi au cours du lupus erythemateux systemique: role du parvovirus B19. Ann Med Interne (Paris) 142: 259-264, 1991.
109. Y Eizuru, T Minematsu, Y Minamishima. Human herpesvirus 6 in lymph nodes. Lancet 1:40, 1989.
110. M Kikuchi, M Yoshizumi, H Nakamura. Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch A Pathol Anat Histol 376:247-253, 1977.
111. Y Takano, M Saegusa, M Okudaira. Pathologic analyses of non-overt necrotizing type Kikuchi and Fujimoto’s disease. Acta Pathol Jpn 43:635-645, 1993.
112. HC Hollingsworth, SC Peiper, LM Weiss, M Raffeld, ES Jaffe. An investigation of the viral pathogenesis of Ki-kuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med 118:134-140, 1994.
113. J Huh, HS Chi, SS Kim, G Gong. A study of the viral etiology of histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). J Korean Med Sci 13:27-30, 1998.
114. CE Garcia, HV Girdhar-Gopal, DM Dorfman. Kikuchi-Fujimoto disease of the neck: update. Ann Otol Rhinol Laryngol 102:11-15, 1993.
115. JK Chan, KC Wong, CS Ng. A fatal case of multicentric Kikuchi’s histiocytic lymphadenitis. Cancer 63: 1856-1862, 1989.
116. T Kuo. Cutaneous manifestations of Kikuchi’s histiocytic necrotizing lymphadenitis. Am J Surg Pathol 14:872-876, 1990.
117. A Seno, R Torigoe, K Shimoe, J Tada, J Arata, M Suwaki. Kikuchi’s disease (histiocytic necrotizing lymphadenitis) with cutaneous involvement. J Am Acad Dermatol 30: 504-506, 1994.
118. GC Ejeckam, B Azadeh, I Matar, O Aboud. Kikuchi’s lymphadenitis in Qatar. East Afr Med J 70:575-577,1993.
119. AR Lifson, JF Hilton, JL Westenhouse, AJ Canchola, MC Samuel, MH Katz, SP Buchbinder, NA Hessol, DH Osmond, S Shiboski, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 8:73-79, 1994.
120. PA Reichart, A Langford, HR Gelderblom, HD Pohle, J Becker, H Wolf. Oral hairy leukoplakia: observations in 95 cases and review of the literature. J Oral Pathol Med 18:410-415, 1989.
121. S Jahn, HW Busch, P Altmeyer. Oral hairy leukoplakia in HIV-positive patients. J Am Acad Dermatol 38:284-285, 1998.
122. R Husak, C Garbe, CE Orfanos. Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol 35:928-934, 1996.
123. CH Shiboski, JF Hilton, JM Neuhaus, A Canchola, D Greenspan. Human immunodeficiency virus-related oral manifestations and gender. Arch Intern Med 156: 2249-2254, 1996.
124. AW Boulter, N Soltanpoor, AV Swan, W Birnbaum, NW Johnson, CG Teo. Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals. AIDS 10:935-940, 1996.
125. LJ Conley, TJ Bush, SP Buchbinder, KA Penley, FN Jud-son, SD Holmberg. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10:1121-1126, 1996.
126. JS Greenspan, MT Mastrucci, PJ Leggott, UK Freese, YG De Souza, GB Scott, D Greenspan. Hairy leukoplakia in a child. AIDS 2:143, 1988.
127. FS Ferguson, H Archard, GJ Nuovo, S Nachman. Hairy leukoplakia in a child with AIDS—a rare symptom: case report. Pediatr Dent 15:280-281, 1993.
128. D Nadal, B De Roche, M Buisson, RA Seger. Oral hairy leukoplakia in vertically and horizontally acquired HIV infection. Arch Dis Child 67:1296-1297, 1992.
129. GN King, CM Healy, MT Glover, JT Kwan, DM Williams, IM Leigh, MH Thornhill. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 78:718-726, 1994.
130. E Eisenberg, D Krutchkoff, H Yamase. Incidental oral hairy leukoplakia in immunocompetent persons. Oral Surg Oral Med Oral Pathol 74:332-333, 1992.
131. DH Felix, K Watret, D Wray, JC Southam. Hairy leukoplakia in an HIV-negative, nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol 74:563-566, 1992.
132. F Lozada-Nur, J Robinson, JA Regezi. Oral hairy leukoplakia in nonimmunosuppressed patients: report of four cases. Oral Surg Oral Med Oral Pathol 78:599-602,1994.
133. L Resnick, JS Herbst, DV Ablashi, S Atherton, B Frank, L Rosen, SN Horwitz. Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA 259: 384-388, 1988.
134. CV Sumaya, RN Boswell, Y Ench, DL Kisner, EM Hersh, JM Reuben, PW Mansell. Enhanced serological and viro-logical findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis 154: 864-870, 1986.
135. GR Alsip, Y Ench, CV Sumaya, RN Boswell. Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis 157:1072-1076, 1988.
136. DM Walling, SN Edmiston, JW Sixbey, M Abdel-Hamid, L Resnick, N Raab-Traub. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A 89:6560-6564, 1992.
137. DM Walling, N Raab-Traub. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol 68: 7909-7917, 1994.
138. DM Walling, AG Perkins, J Webster-Cyriaque, L Resnick, N Raab-Traub. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic deletion, and transcriptional expression. J Virol 68:7918-7926, 1994.
139. DM Walling, NM Clark, DM Markovitz, TS Frank, DK Braun, E Eisenberg, DJ Krutchkoff, DH Felix, N Raab-Traub. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 171:1122-1130, 1995.
140. CW Dawson, AG Eliopoulos, J Dawson, L Young. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 10:69-77, 1995.
141. K Gilligan, P Rajadurai, L Resnick, N Raab-Traub. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A 87:8790-8794, 1990.
142. JS Greenspan, D Greenspan. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol 67:396-403, 1989.
143. S Kabani, D Greenspan, Y de Souza, JS Greenspan, E Cataldo. Oral hairy leukoplakia with extensive mucosal involvement. Oral Surg Oral Med Oral Pathol 67:411-415, 1989.
144. E Lucht, P Biberfeld, A Linde. Epstein-Barr virus (EBV) in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. J Infect 31:189-194, 1995.
145. E Brehmer-Andersson, E Lucht, S Lindskog, M Ekman, P Biberfeld. Oral hairy leukoplakia: pathogenetic aspects and significance of the lesion. Acta Derm Venereol 74: 81-89, 1994.
146. TE Daniels, D Greenspan, JS Greenspan, E Lennette, M Schiodt, V Petersen, Y de Souza. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion. J Invest Dermatol 89:178-182, 1987.
147. L Anderson, HP Philipsen, PA Reichart. Macro- and microanatomy of the lateral border of the tongue with special reference to oral hairy leukoplakia. J Oral Pathol Med 19: 77-80, 1990.
148. TL Green, JS Greenspan, D Greenspan, YG de Souza. Oral lesions mimicking hairy leukoplakia: a diagnostic dilemma. Oral Surg Oral Med Oral Pathol 67:422-426, 1989.
149. DA Fisher, TE Daniels, JS Greenspan. Oral hairy leukoplakia unassociated with human immunodeficiency virus: pseudo oral hairy leukoplakia. J Am Acad Dermatol 27: 257-258, 1992.
150. S Euvrard, J Kanitakis, C Pouteil-Noble, Y Chardonnet, JL Touraine, J Thivolet. Pseudo oral hairy leukoplakia in a renal allograft recipient. J Am Acad Dermatol 30: 300-303, 1994.
151. CA Migliorati, AC Jones, PA Baughman. Use of exfoliative cytology in the diagnosis of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 76:704-710, 1993.
152. G Gowdey, RK Lee, WM Carpenter. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:64-67, 1995.
153. CM Nichols, CM Flaitz, MJ Hicks. Role of podophyllin resin therapy in oral hairy leukoplakia in HIV infection: clinicopathologic study (abstr). Proceedings of the XI International Conference on AIDS, Vancouver, Canada, 1996.
154. H Schoffer, FR Ochsendorf, EB Helm, R Milbradt. Treatment of oral “hairy” leukoplakia in AIDS patients vitamin A acid (topically) or acyclovir (systemically). Dermatologica 174:150-151, 1987.
155. BT Goh, RKW Lau. Treatment of AIDS-associated oral hairy leukoplakia with cryotherapy. Int J STD AIDS 5: 60-62, 1993.
156. JS Herbst, J Morgan, N Raab-Traub, L Resnick. Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol 21:753-756, 1989.